{"name":"Antonio Martín Duce","slug":"antonio-mart-n-duce","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Dipyrone administration","genericName":"Dipyrone administration","slug":"dipyrone-administration","indication":"Other","status":"marketed"},{"name":"beta-endorphin immunoreactivity","genericName":"beta-endorphin immunoreactivity","slug":"beta-endorphin-immunoreactivity","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"Dipyrone administration","genericName":"Dipyrone administration","slug":"dipyrone-administration","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"beta-endorphin immunoreactivity","genericName":"beta-endorphin immunoreactivity","slug":"beta-endorphin-immunoreactivity","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":2,"phaseCounts":{"marketed":2},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}